LIFE TECHNOLOGIES CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 76 rows in 2010. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2010-12-29: Reporting owner Brust Bernd; Form 4; Security Stock Options; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2010-12-22: Reporting owner BARTHELEMY NICOLAS; Form 4; Security Stock Options; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2010-12-17: Reporting owner Miller John L; Form 4/A; Security Stock Options; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2010-12-17: Reporting owner Miller John L; Form 4/A; Security Stock Options; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2010-12-29 | Brust Bernd Officer (President, Molecular Medicine) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,250 0 owned after | $27.51 exercise price | 2011-01-03 | |
| 2010-12-22 | BARTHELEMY NICOLAS Officer (Pres, Commercial Operations) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,036 0 owned after | $32.94 exercise price | 2010-12-23 | |
| 2010-12-17 | Miller John L Officer (President, Genetic Systems) | 4/A | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 93,623 owned after | $22.23 exercise price | 2010-12-21 | |
| 2010-12-17 | Miller John L Officer (President, Genetic Systems) | 4/A | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −28,208 96,623 owned after | $22.23 exercise price | 2010-12-21 | |
| 2010-12-17 | Miller John L Officer (President, Genetic Systems) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 93,623 owned after | $22.23 exercise price | 2010-12-21 | |
| 2010-12-17 | Miller John L Officer (President, Genetic Systems) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −28,208 96,623 owned after | $22.23 exercise price | 2010-12-21 | |
| 2010-12-15 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −500 0 owned after | $35.53 exercise price | 2010-12-16 | |
| 2010-12-14 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −500 500 owned after | $35.53 exercise price | 2010-12-16 | |
| 2010-12-13 | RICHARD KELLI Officer (Chief Accounting Officer) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,791 8,373 owned after | $29.15 exercise price | 2010-12-14 | |
| 2010-12-13 | RICHARD KELLI Officer (Chief Accounting Officer) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 0 owned after | $32.94 exercise price | 2010-12-14 | |
| 2010-12-13 | RICHARD KELLI Officer (Chief Accounting Officer) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,750 3,750 owned after | $30.29 exercise price | 2010-12-14 | |
| 2010-12-13 | RICHARD KELLI Officer (Chief Accounting Officer) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,750 3,750 owned after | $35.87 exercise price | 2010-12-14 | |
| 2010-12-10 | IYER BALAKRISHNAN S Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,800 0 owned after | $30.59 exercise price | 2010-12-14 | |
| 2010-12-10 | IYER BALAKRISHNAN S Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,200 2,800 owned after | $30.59 exercise price | 2010-12-14 | |
| 2010-12-10 | COTTINGHAM JOHN A Officer (Chief Legal Officer) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,096 0 owned after | $22.82 exercise price | 2010-12-13 | |
| 2010-12-10 | COTTINGHAM JOHN A Officer (Chief Legal Officer) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −35,304 0 owned after | $22.82 exercise price | 2010-12-13 | |
| 2010-12-10 | BARTHELEMY NICOLAS Officer (Pres, Commercial Operations) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −31,208 62,415 owned after | $22.23 exercise price | 2010-12-13 | |
| 2010-12-03 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 1,000 owned after | $35.53 exercise price | 2010-12-07 | |
| 2010-12-03 | Brust Bernd Officer (Pres, Commercial Operations) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −31,208 62,415 owned after | $22.23 exercise price | 2010-12-06 | |
| 2010-12-02 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 5,000 owned after | $31.86 exercise price | 2010-12-03 | |
| 2010-11-05 | DITTAMORE RAYMOND V Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 0 owned after | $30.59 exercise price | 2010-11-08 | |
| 2010-11-04 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 6,000 owned after | $31.86 exercise price | 2010-11-08 | |
| 2010-11-03 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 2,000 owned after | $35.53 exercise price | 2010-11-04 | |
| 2010-11-03 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 7,000 owned after | $31.86 exercise price | 2010-11-04 | |
| 2010-09-09 | GRIMM DONALD W Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 0 owned after | $33.31 exercise price | 2010-09-13 | |
| 2010-08-20 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 8,000 owned after | $31.86 exercise price | 2010-08-24 | |
| 2010-06-15 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 5,000 owned after | $35.53 exercise price | 2010-06-16 | |
| 2010-06-15 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 4,000 owned after | $35.53 exercise price | 2010-06-16 | |
| 2010-06-15 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 3,000 owned after | $35.53 exercise price | 2010-06-16 | |
| 2010-06-15 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 9,000 owned after | $31.86 exercise price | 2010-06-16 | |
| 2010-06-14 | Dansky Peter Officer (Pres, Molecular Biology Sys) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,700 108,831 owned after | $22.23 exercise price | 2010-06-15 | |
| 2010-06-11 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −500 6,000 owned after | $35.53 exercise price | 2010-06-15 | |
| 2010-06-11 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −500 10,000 owned after | $31.86 exercise price | 2010-06-15 | |
| 2010-06-10 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 7,000 owned after | $35.53 exercise price | 2010-06-11 | |
| 2010-06-10 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −500 6,500 owned after | $35.53 exercise price | 2010-06-11 | |
| 2010-06-10 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −500 12,500 owned after | $31.86 exercise price | 2010-06-11 | |
| 2010-06-09 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −500 8,000 owned after | $35.53 exercise price | 2010-06-10 | |
| 2010-06-09 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −500 13,000 owned after | $31.86 exercise price | 2010-06-10 | |
| 2010-06-03 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −500 8,500 owned after | $35.53 exercise price | 2010-06-07 | |
| 2010-06-03 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −500 13,500 owned after | $31.86 exercise price | 2010-06-07 | |
| 2010-05-28 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 9,000 owned after | $35.53 exercise price | 2010-06-01 | |
| 2010-05-27 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 10,000 owned after | $35.53 exercise price | 2010-05-28 | |
| 2010-05-26 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 11,000 owned after | $35.53 exercise price | 2010-05-27 | |
| 2010-05-21 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 12,000 owned after | $35.53 exercise price | 2010-05-24 | |
| 2010-05-13 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 0 owned after | $36.18 exercise price | 2010-05-17 | |
| 2010-05-12 | Dansky Peter Officer (Pres, Molecular Biology Sys) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,000 111,531 owned after | $22.23 exercise price | 2010-05-14 | |
| 2010-05-12 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 14,000 owned after | $31.86 exercise price | 2010-05-14 | |
| 2010-05-07 | Dansky Peter Officer (Pres, Molecular Biology Sys) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,300 117,531 owned after | $22.23 exercise price | 2010-05-11 | |
| 2010-04-29 | BARTHELEMY NICOLAS Officer (President, Cell Systems) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,500 11,464 owned after | $32.94 exercise price | 2010-05-03 | |
| 2010-03-15 | BARTHELEMY NICOLAS Officer (President, Cell Systems) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,208 93,623 owned after | $22.23 exercise price | 2010-03-17 | |
| 2010-03-15 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 3,000 owned after | $36.18 exercise price | 2010-03-17 | |
| 2010-03-12 | O'Donnell Mark Sean Officer (SVP, Global Ops & Services) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,436 0 owned after | $24.69 exercise price | 2010-03-16 | |
| 2010-03-12 | O'Donnell Mark Sean Officer (SVP, Global Ops & Services) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,436 0 owned after | $24.69 exercise price | 2010-03-16 | |
| 2010-03-12 | O'Donnell Mark Sean Officer (SVP, Global Ops & Services) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −19,135 0 owned after | $39.81 exercise price | 2010-03-16 | |
| 2010-03-11 | Beery Joseph C Officer (SVP, Chief Information Officer) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,896 17,688 owned after | $29.15 exercise price | 2010-03-12 | |
| 2010-03-11 | Beery Joseph C Officer (SVP, Chief Information Officer) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,548 61,643 owned after | $36.50 exercise price | 2010-03-12 | |
| 2010-03-10 | Dansky Peter Officer (Pres, Molecular Biology Sys) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,000 118,831 owned after | $22.23 exercise price | 2010-03-12 | |
| 2010-03-02 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 4,000 owned after | $36.18 exercise price | 2010-03-03 | |
| 2010-03-01 | Stevenson Mark Officer (President & COO) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +84,516 84,516 owned after | $52.00 | 2010-03-03 | |
| 2010-03-01 | RICHARD KELLI Officer (Chief Accounting Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,283 20,283 owned after | $52.00 | 2010-03-03 | |
| 2010-03-01 | Leddy Peter Michael Officer (SVP, Global Human Resources) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,567 40,567 owned after | $52.00 | 2010-03-03 | |
| 2010-03-01 | O'Donnell Mark Sean Officer (SVP, Global Ops & Services) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,567 40,567 owned after | $52.00 | 2010-03-03 | |
| 2010-03-01 | Grossman Paul David Officer (SVP, Corporate Strategy & Dev.) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,567 40,567 owned after | $52.00 | 2010-03-03 | |
| 2010-03-01 | Miller John L Officer (President, Genetic Systems) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,187 37,187 owned after | $52.00 | 2010-03-03 | |
| 2010-03-01 | Brust Bernd Officer (Pres, Commercial Operations) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +74,374 74,374 owned after | $52.00 | 2010-03-03 | |
| 2010-03-01 | LUCIER GREGORY T Officer (Chief Executive Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +243,407 243,407 owned after | $52.00 | 2010-03-03 | |
| 2010-03-01 | Hoffmeister David F Officer (Chief Financial Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +67,613 67,613 owned after | $52.00 | 2010-03-03 | |
| 2010-03-01 | Beery Joseph C Officer (SVP, Chief Information Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +33,806 33,806 owned after | $52.00 | 2010-03-03 | |
| 2010-03-01 | Dansky Peter Officer (Pres, Molecular Biology Sys) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,709 50,709 owned after | $52.00 | 2010-03-03 | |
| 2010-03-01 | BARTHELEMY NICOLAS Officer (President, Cell Systems) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,187 37,187 owned after | $52.00 | 2010-03-03 | |
| 2010-03-01 | COTTINGHAM JOHN A Officer (Chief Legal Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,567 40,567 owned after | $52.00 | 2010-03-03 | |
| 2010-03-01 | Brust Bernd Officer (Pres, Commercial Operations) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,750 11,750 owned after | $28.30 exercise price | 2010-03-02 | |
| 2010-02-19 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 5,000 owned after | $36.18 exercise price | 2010-02-22 | |
| 2010-02-18 | UPRICHARD DAVID C Director | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,000 6,000 owned after | $36.18 exercise price | 2010-02-19 | |
| 2010-02-17 | Grossman Paul David Officer (SVP, Corporate Strategy & Dev.) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,794 64,430 owned after | $22.23 exercise price | 2010-02-19 | |
| 2010-02-17 | Grossman Paul David Officer (SVP, Corporate Strategy & Dev.) | 4 | Stock Options Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,762 55,668 owned after | $22.23 exercise price | 2010-02-19 |